Lawsuit challenges Louisiana law classifying mifepristone, misoprostol as controlled substances

Lawsuit challenges Louisiana law classifying mifepristone, misoprostol as controlled substances

Healthcare workers and advocates in Louisiana are challenging a law re-classifying medication abortion drugs as controlled substances, arguing it restricts access to essential care, particularly impacting Black women. The lawsuit seeks to halt enforcement of the law.

Read More

Did you find this insightful?